Macroview Investment Management LLC Lantheus Holdings, Inc. Transaction History

Macroview Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$58.87 - $83.05 $5,474 - $7,723	93 New	93 $7,000
Q2 2023 Jul 13, 2023	SELL	$82.41 - $99.65 $247 - $298	-3 Reduced 2.14%	137 $11,000
Q1 2023 Apr 18, 2023	SELL	$47.76 - $82.86 $4,680 - $8,120	-98 Reduced 41.18%	140 $11,000
Q4 2022 Jan 11, 2023	BUY	$48.76 - $77.67 $4,583 - $7,300	94 Added 65.28%	238 $0
Q3 2022 Oct 21, 2022	BUY	$61.42 - $86.29 $8,844 - $12,425	144 New	144 $10,000

512

67.2M

1.19M

837K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $7.42B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.